Introduction
Sincethe earlytwentiethcentury,kojicacid (5-hydroxy-2-hydroxymethyl-4H -pyran-4-one) hasbeen knownas anadditivetop reventbrowning of food materialsin the food industry,asanantioxidantin ordertopreserve theirfreshness and toi nhibitdiscoloration. Ab iologicallyimportantnaturalsubstance,itisanantibiotic produced bymanys peciesof fungi orbacteria, suchas Aspergillus oryzae , Penicillium or Acetobacter spp. in an aerobicprocess from awide range of carbon sources [1] [2] [3] .Ithasplayed ani mportantr ole in iron-overload diseasess uchas b -thallasemiaoranemia, sincei tpossessesiron chelating activity [2, [4] [5] [6] .Italsof ormed stable complexest hatt he metalk ojatesw erep repared byr eaction of kojica cid withm etalacetatesalts [3, 7, 8] .Additionally,kojica cid and its derivativeshave showntop ossess various bioactivitiess uchasantimicrobial [2, 3, [9] [10] [11] [12] [13] , cosmeticskin-whitening [1, 3, 14] , herbicidal [9, 15] , anti-speck [16] , pesticide and insecticide [17, 18] , antitumor [19, 20] , anti-diabetic [ 21] a nd antiproliferativeactivities [22] . Epilepsy,the most common serious neurologicald isordercharacterized byrecurrentunprovoked seizures,is estimated toaffectapproximately6 0million people worldwide. Especially,the majority of casesisin developing countries.Morethan30 %o fp atients withe pilepsy havei nadequatecontrol of seizuresw ithavailable medicaltherapies.The established conventionalantiepilepticdrugslike phenytoin,c arbamazepine,ethosuximide,valproicacid and barbiturates,though widelyprescribed,exhibited unfavorable side effectprofiless uch asdrowsiness,a taxia, hepatotoxicity,gingivalh yperplasia, and megaloblastica nemiaa nd failured tocontrol seizuresadequately.Inrecenty ears,severaln ewantiepilepticdrugssuchaslamotrigine,oxcarbazepine,felbamate,gabapentin,topiramate,fosphenytoin sodium, tigabine,zonisamide and levetiracetamh avebeen approved. Some of the mechanismsof newantiepileptic drugsinclude potentiation of c -aminobutyrica cid (GABA)-ergictransmission,b lockage of voltage-dependents odiumchannels,a ttenuation of excitatory neurotransmission,a nd modulation of voltage-sensitivecalciumchannels [23 -26] .Therei scontinuing demand
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fornewanticonvulsantagents,a sithasnotbeen possible tocontrol every kind of seizurewiththe currently available antiepilepticdrugs.Top rovide improvement of the quality of life of people suffering from epilepsy, itisessentialtosearchf ornewerchemicale ntitiesw ith lowertoxicity and fewerside effects forthe treatmentof epilepsy.
Kojica mine (2-aminomethyl-5-hydroxy-4H -pyran-4-one) hasbeen found top ossess GABA agonist activity ( Fig. 1) [27, 28] .The earlyneuropharmacologicalp rofile of kojica mine resulted in its classification asaG ABA A receptoragonist [29, 30] .When compared withthe structureo fGABA, the similarity of muscimol,aGABAlike agent,a nd kojica mine isapparent.
Kojica cid hasw eakeractivity thane thylmaltol (2-ethyl-3-hydroxy-4H -pyran-4-one) (Fig. 2) against the convulsionsinduced bymetrazole and strychnine. The increaseo fthe inhibitory effectof 2-alkyl-3-hydroxy-4 H -pyran-4-oneson metrazol-induced convulsion with increasing carbon numberof the alkylg roupm ightbe duetoe nhancementof lipid solubility [31, 32] .Ino ur previous studies,wereported thatMannichbasesof allomaltol derivativesshowed anticonvulsantand antifungalactivities [13, 31, 32] .
Incontinuation of our earlierw ork,the presentpaper reports on the synthesis,a nticonvulsantand neurotoxicity evaluation of some newkojicacid derivatives.3-Hydroxy-6-hydroxymethyl-2-substituted 4 H -pyran-4-one derivatives( 1-15)whicharecarrying various substituted piperazine derivativesatt he 2 nd position ( Fig. 2) ared esigned aslipophilica gents.Thereforethesecompoundsmightbetransferred intothe centralspinalfluid and brain easily. 
2.Materialand methods

Chemistry
Generalsynthesisof Mannichbases(Scheme 1)
Mannichbaseswereprepared bythe reaction of substituted piperazine derivatives(0.01m ol) and kojica cid (0.01m ol) in methanol with37 %f ormaline. The mixturewass tirred vigorouslyfor15 to25min. The resulting precipitatewascollected byfiltration and washed withcold methanol.The crude productwasr ecrystallized from methanol orchloroform. 2-(4-Acetylpiperazin-1-ylm ethyl)-3-hydroxy-6-hydroxymethyl-4H-pyran-4-one ( 14) 
2.1.2Analyticald ataforsome compounds
3-Hydroxy-6-hydroxymethyl-2-[4-(3-trifluoromethylphe- nyl)piperazin-1-ylmethyl]-4H-pyran-4-one ( 4 ) IR (KBrdisc)1 648 (C=Ost),1503 (C=Cst),1113cm -1 (C-Ost). 1 H-NMR d (DMSO-d 6 ,
2-[4-(4-
Fluorophenyl)piperazin-1-yl- methyl]-3-hydroxy-6-hydroxymethyl- 4H-pyran-4-one ( 6 ) IR (KBrdisc)1 613(C=Ost),1514,1461 (C=Cst),1205cm -1 (C-Ost). 1 H-NMR d (DMSO-d 6 ,
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3-Hydroxy
-6-hydroxymethyl-2-[4-(2-methoxyphenyl)pi- perazin-1-ylmethyl]-4H-pyran-4-one ( 7 ) IR (KBrdisc)1611 (C=Ost),1501,1460 (C=Cst),1202 cm -1 (C-O st2-[4-(3-Chlorophenyl)piperazin-1-ylmethyl]-3-hydroxy- 6-hydroxymethyl-4H-pyran-4-one ( 10 ) IR (KBrdisc)1 642(C=Ost),1487(C=Cst),1221cm -1 (C-Ost). 1 H-NMR d (DMSO-d 6 ,
2-[4-(4-
Chlorophenyl)piperazin-1-ylmethyl]-3-hydroxy- 6-hydroxymethyl-4H-pyran-4-one ( 11) IR (KBrdisc)1615 (C=Ost),1501,1461(C=Cst),1205cm -1 (C-O stIR (KBrdisc)1630,1610(C=Ost),1488 (C=Cst),1217cm -1 (C-O st
2.2Pharmacology
The compoundsw eretested fort heiranticonvulsantactivity against maximale lectroshock( MES)and subcutaneous Metrazol (scMet)induced seizurethreshold tests.The acuteneurologicaltoxicity wasdetermined in the rotorod test.All thesetests werep erformedi nm ale miceaccording tothe PhaseItests of the AntiepilepticD rugDevelopment(ADD)p rogramwhich wered evelopedbyt he NationalInstitutesof Health( NIH)and NationalInstituteo fNeurologicalDisorders and Stroke (NINDS) [35] .Thisprogramwasused forthe screening of many compoundsin various previous studies [13, 33, 34] 
Maximale lectroshock( MES)induced seizure test
MES seizuresw eree licited witha60-cycle alternating current of 50mAintensity (5 -7t imesmorethanthatr equired toe licit minimalseizures)d elivered for0 .2s viac orneale lectrodes.A drop of 0.9 %saline wasinstilled intothe eyep riort oapplication of the electrodesin ordert op reventt he deatho fthe animal. Abolition of the hind limbtonicextensioncomponentof the seizurewasdefined asprotection.
2.2.2Subcutaneous Metrazol (ScMet)test
85 mg/kg of Metrazol (producess eizuresin morethan9 5% of mice) wasadministered asa0.5 %solution s.c.intothe posteriormidline. The animalwasobserved for3 0min tod ecide whethert he failureo fthe threshold seizure( asingle episode of clonicspasmsof atleast 5sduration) could bed efined as protection.
2.2.3Neurotoxicity
The rotorod test wasused toevaluateneurotoxicity.The animal wasplaced on a1inchd iameterknurled wooden rod rotating at6rpm. Normalm iceremain on arod rotating att hiss peed indefinitely.Neurologictoxicity wasdefined ast he failureo f the animaltoremain on the rod for1m in.
3.Results
Chemistry
Kojica cid containsapolyfunctionalh eterocyclic, oxygen containing ring withseverali mportantcenters enabling additionalreactionslike oxidation and reduction, alkylation and acylation,substitution nucleophilicreac- Itisw ell knownthathydroxypyranonescane xist in cationica nd anionicformsduetothe protonation or deprotonation reactions,respectively.The hydroxyl groupthatisdirectlybound tothe pyranone ring was probablymored eprotonated thanthe hydroxymethyl group. Quantumm echanicali nvestigationson tautomericequilibriaof kojica cid werep erformed. Because of twointramolecularhydrogen bonds,the enolicstructureo fn eutralk ojica cid isexpected tobethe most stable one. One of thesetwobondsislocated between the ketoand hydroxylg roupsand the otherhydrogen bond canbeformed weaklybetween the hydroxymethyl moiety and intra-ring oxygen [5] .
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Ino ur previous studies,the structuresof some Mannichbasesw ered etermined byx -rayanalysis.The conformation of the molecule isdetermined byintra-and intermolecularhydrogen bonds.Some weaki ntramolecularinteractionshelped tostabilizethe structure. The piperazine ring displayed analmost perfectchairconformation [41, 42] .
Multicomponentr eactionsarethe majorparts of the syntheticorganicc hemistry withadvantagesr anging from lowerr eaction timesand temperaturest oh igher yields.Mannich-type reactionsareathree-component condensation reaction involving carbonylcompounds, whiche xist asketo-enol tautomersicforms,formaline and aprimary ors econdary amine. In1 912,M annich and Krosche werethe first top reparesome Mannich basesonlyin the 6 th position,whichisthe reactiveposition of kojica cid [37] .Duetop henol-like properties kojica cid readilyu ndergoesaminomethylation in the Mannichreaction ortho tothe enolichydroxylg roupat room temperature. Later,di-Mannichd erivativesof kojica cid weresynthesized in anacid mediumby Woods [43] .Mannichbasesof kojica cid derivatives whichshowv arious biologicalactivitiesw erep repared and evaluated fortheiractivitiesbydifferentresearchers [13, 33, 34, 37, 39] . Inthisstudy,the synthesisof 15 3-hydroxy-6-hydroxymethyl-2-substituted 4 H -pyran-4-one derivativesw ere prepared asMannichbasesbyt he method showni n Scheme 1. The commerciallyavailable kojica cid was used ass tarting material. The Mannichbasesof kojic acid weref ormed byt he reaction of appropriatelys ubstituted piperazine derivativesw ithk ojica cid and 37 % formaline atr oom temperaturei nm ethanol. Mannich basesobtained atthe 2 nd position becauseofthe hydroxylgroupatthe 3 rd position on the 4 H -pyran-4-one ring.
The reaction proceeded very rapidly. All the compoundsw erep repared asnewproducts exceptcompound 1 (CAS 303033-62-7)i sac ommercial productin "ScienceFinder2 007". Sincetherei sno information in the literatureforthe preparation and spectralcharacteristics,thiscompound hasbeen included in our researchp rogramme and characterized bys pectral data).
Formation of the desired Mannichbasesw asconfirmed on the basisof elementary analysisand structuresof compoundsw eresupported bys pectrald ata. 
3.2Anticonvulsantactivity
Inthe presents tudy,some newderivativesof kojica cid havebeen synthesized aspotentialanticonvulsantcompoundsaccording top revious studies [13, 33, 34] .The anticonvulsantactivitiesof the compoundsw erei nitiallyevaluated in MES and scMets eizuretests induced 0.5 and 4hafteradministration at3 0,100 and 300 mg/ kg dosesu sing Swiss albino male mice( 20 AE 2g). Preliminary screening results arepresented in Table 2 . According tothe results of the anticonvulsantactivity studies,3-hydroxy-6-hydroxymethyl-2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]-4H -pyran-4-one (compound 7 )washighlys electiveand found tobethe most activecompound against scMets eizuresatall dosesat 0.5 and 4h.Inthe same test,while compound 6 ,which iscarrying a4-fluorophenylmoiety,wasprotectiveatall dosesat0.5 hand atthe 100 and 300 mg/kg dosesat4h, compound 10 ,whichi scarrying a3-chlorophenylm oiety,wasfound toh aveanticonvulsantactivity atall dosesat4h and att he 300 mg/kg doseat0 .5 h. Compound 2 showed activity against scMets eizuresat100 and 300 mg/kg at4h and 300 mg/kg at0 .5 h. Compounds 3 , 4 , 5 , 11 and 13 werep rotectiveagainst scMet seizures3 00 mg/kg at4h.Some compoundslike 3 , 8 and 11 werealsoactiveat100 and 300 mg/kg dosesat 0.5 h. Compounds 4 and 9 exhibited activity att he 100 mg/kg doseat0 .5 h.
Inthe MES test the most activecompound of the groupo ftested compoundsw as2 -[4-(4-chlorophenyl)-piperazin-1-ylmethyl]-3-hydroxy-6-hydroxymethyl-4 H -pyran-4-one (compound 11)atall dosesat0.5 hand 4h.Considering the results at4h,c ompounds 4 , 9 and 15,whicharecarrying atrifluoromethyl,2-chlorophenyl and tert-butylcarboxylatem oiety att he 2 nd position on the pyran-4(1H )-one ring,respectively,weredetermined top rotectagainst seizuresatall dosesin thiss eries. Also,c ompound 14 whichi scarrying a4-acetylm oiety showed selectiveactivity atall dosesat0 .5 hand att he 300 mg/kg doseat4h.Att he 300 mg/kg dose,while compounds 1 , 4 , 10 and 13 showed activity at0 .5 h, compounds 2 , 5 , 6 and 14 weree stablished tobep rotectiveat4h.Besidest his,c ompound 8 washaving activity at100 and 300 mg/kg dosesat0.5 h. While 2-fluorophenyl( 5 )and 4-fluorophenyl( 6 )d erivativesw ere protectiveagainst MES seizuresat4h toasimilardegree,c ompound 6 showed greateractivity thancompound 5 against scMets eizures . Onlycompound 12 did nots howanticonvulsantactivity in anyt est.
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Forprivateorinternal corporateuseonly Compoundswithasubstituted piperazine ring suchas phenyl( 1 ),2-pyridine ( 12 )and pyrimidine ( 13 )rings weref ound toh avel owerorno activity thanthe others whichhaveapiperazine ring containing substituted phenyl( 2-11 ),a cetyl ( 14) and tert-butylcarboxylate ( 15) . Presenceofanelectron richgroupattached tothe phenyl ring showed increased potencyin bothseizuretests.In addition,while the 2-fluorophenylderivative(5 )wasnot protective,the 4-fluorophenyld erivative( 6 )showed activity against scMetseizuresatall doseat0.5 h. Also,only 2-(9 )and 4-chlorophenyl(11)derivativeswereeffective in the MES test at4h;the 3-chlorophenyl(10 )derivative wasnotactivebeside the chloroseries.Conversely,in the scMettest at4h,compound 10 wasthe most activecompound in thisseries.2-Methoxy ( 7 )derivativeshowed selectiveactivity against scMetseizures,but the 3-methoxy ( 8 )d erivativewasnots electiveand wasless activethan compound 7 .Also,compounds 14 and 15 wereselective protectivecompoundsin the MES tests.Itseemsthatthe compoundsin the seriesof substituted phenylpiperazine with3-trifluoromethyl,2-and 4-chloroaremoresuitable forthe MES tests,while derivativeswith4-fluoro,2-methoxy and 3-chloroyielded the most activecompoundsin the scMettests.None of the compoundsshowed neurotoxicity according tothe rotorod test atanyof the doses studied.
Discussion
Ino ur previous studies,3-hydroxy-6-methyl-2-substituted 4 H -pyran-4-one derivativesw eree valuated for theiranticonvulsantactivity.Itisgenerallyaccepted thatt he lipid solubility of adrugi sani mportantfactor in connection withi ts transferintothe centralspinal fluid and brain. Also,substitution of differentlipophilic phenyld erivativesatt he 4 th position of the piperazine ring enablespenetration of the blood-brain barrier.The effects of mono substitution of the phenylgroupwithan electron donating orelectron withdrawing groupatt he ortho,metaa nd paraposition weree xamined. According tothe results,thesecompounds,especially4-chlorophenyland 3-trifluoromethylphenyld erivatives,had marked anticonvulsantactivity in scMetand MES tests [13] .When substituted piperidine derivativesand morpholine ring att he 2 nd position of allomaltol (Fig. 2) wereused insteadofthe piperazine ring,the anticonvulsantactivity of theseMannichbasesw asdecreased [33, 34] . Insteado fallomaltol,used ass tarting materiali nf ormerstudies,in thisstudykojicacid wasused. Thesetwo starting materialsdifferonlyin the methylo rhydroxymethylg roupsatt he 6 th position of the pyranone ring.
Bothk ojica cid and allomaltol derivatives,including 4-chloroand 3-trifluoromethylphenylpiperazine,were protectiveagainst all seizures.When the effects of differentpiperazine ringsu pon activity weree xamined,kojic acid derivativesw eref ound tobem oreactivethanallomaltol derivatives.Onthe otherhand,when the results of thiss tudyw erecompared withthoseo fo ur previous studies,replacementof hydroxymethylwithamethyl groupatt he 6 th position of the pyranone ring increased the protectiveeffectin bothtests,becauseoftwohydrogen bondsof kojica cid,whicharel ocated between the ketoand hydroxylg roupand/orhydroxymethylm oiety and intra-ring oxygen. Our structure-activity relationship (SAR)studies showed thatt he promising anticonvulsantdrugscontain electronegativeg roupsadjacentt othe phenylring, including nitro,a cetyl,trifluoromethyl,fluoro,c hloro and methoxy.The otheractivederivativesinclude acarbonyl( acetyl) orester( tert-butylcarboxylate) insteado f the phenylring.
Conclusion
Aseriesof novel Mannichbasesof kojica cid,namely 3-hydroxy-6-hydroxymethyl-2-(substituted piperazin-1-yl)methyl-4H -pyran-4-onesw eresynthesized and studied foranticonvulsantactivity in MES and scMett ests. Inthe Mannichbasesseries,forall doses,at0.5 and 4h, while compound 7 wasfound toh avesignificantlyhigh selectiveanticonvulsantactivity against scMets eizures, compound 11 wasdetermined tobethe most active against MES seizures.Atall doses,c ompounds 4 , 9 , 11, 14 and 15 weref ound toh aveanticonvulsantactivity against MES seizuresand compounds 6 , 7 and 10 were protectiveagainst scMets eizures.Inthe rotorod neurotoxicity screening none of the compoundss howed toxicity atanydose.
The results of thiss tudyr evealed thatanticonvulsant activity of Mannichbaseshaseffectivelyincreased in comparison witho ur previous studies.Itcanbesuggested thatthe increaseinactivity dependson the structureo fk ojica cid,used ass tarting material,whichi ncludest woh ydrogen bonds.Generally,most of the synthesized compounds( 4 , 6 , 7 , 9 , 10 , 11, 14 and 15) seemed tobep romising candidatesasnewanticonvulsantcompounds.Inbrief,especiallycompounds 7 and 11 arethe most activecompoundsin theseseries; they mightbep otentiallyu sefuli nthe treatmentof grand maland petitmale pilepsies.
